share_log

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Abdullahi Khullani

Cardio Diagnostics | 4:持股變動聲明-高管 Abdullahi Khullani

SEC announcement ·  02/22 04:16
牛牛AI助理已提取核心訊息
Cardio Diagnostics Holdings, Inc. (CDIO.US) has reported a transaction involving Abdullahi Khullani, the company's VP of Revenue and Strategy. The transaction took place on January 23, 2024. However, specific details regarding the action type, status, number of shares involved, nature of shares, transaction price, post-transaction shareholding, and total value of shares were not disclosed in the announcement.
Cardio Diagnostics Holdings, Inc. (CDIO.US) has reported a transaction involving Abdullahi Khullani, the company's VP of Revenue and Strategy. The transaction took place on January 23, 2024. However, specific details regarding the action type, status, number of shares involved, nature of shares, transaction price, post-transaction shareholding, and total value of shares were not disclosed in the announcement.
Cardio Diagnostics Holdings, Inc.(CDIO.US)報告了一筆涉及該公司收入和戰略副總裁阿卜杜拉希·庫拉尼的交易。該交易於 2024 年 1 月 23 日進行。但是,公告中沒有披露有關行動類型、地位、所涉股票數量、股票性質、交易價格、交易後持股和股票總價值的具體細節。
Cardio Diagnostics Holdings, Inc.(CDIO.US)報告了一筆涉及該公司收入和戰略副總裁阿卜杜拉希·庫拉尼的交易。該交易於 2024 年 1 月 23 日進行。但是,公告中沒有披露有關行動類型、地位、所涉股票數量、股票性質、交易價格、交易後持股和股票總價值的具體細節。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。